Zhenping Chen

Associate professor
Hematologic Diseases Laboratory, Hematology Center, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, ChinaChildren’s Health, Beijing, 100045, China
Beijing, Beijing, China (People's Republic)

Presentation(s):

• OC 05.1 - Machine learning models developed and internally validated for predicting chronicity in pediatric immune thrombocytopenia

  Saturday, June 22, 2024
  13:00 – 13:15 ICT

• PB0506 - Influence of F8 gene mutation on outcome in immune tolerance induction of hemophilia A children with inhibitors

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0604 - Plasma concentration-adjusted dose of eltrombopag for the individualised treatment of immune thrombocytopenia in children：apilot study from Beijing Children’s Hospital

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0621 - Population pharmacokinetics model of BAY81-8973 in Chinese children with severe haemophilia A

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0613 - Real-World Use of Emicizumab in Chinese Children with Hemophilia A: Retrospective Data from a Comprehensive Care Center

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0665 - Th1 cells is the predictive factor of early response to rituximab in children with immune thrombocytopenia

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0546 - The lower double negative T cells proportion predicted the better high-titer inhibitors eradication outcomes of immune tolerance induction

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 41.2 - F8 mutations involving deletion of the F8B gene increase inhibitor risk for hemophilia A

  Monday, June 24, 2024
  15:00 – 15:15 ICT

• OC 41.3 - Single-cell sequencing of PBMCs from hemophilia A and hemophilia B patients with inhibitors reveals different immune responses to FVIII and FIX after replacement therapy

  Monday, June 24, 2024
  15:15 – 15:30 ICT

• PB1256 - Escalating low-dose individualized haemophilia prophylaxis: A focus in China at Dawn of a new era of cost effective Individualized prophylaxis

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT